Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_L01XX
Extra metadata
List of similar endpoints to
L01XX Other antineoplastic agents
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 771 | 376 | 395 |
| Unadjusted prevalence (%) | 0.30 | 0.26 | 0.35 |
| Mean age at first event (years) | 65.73 | 65.02 | 66.41 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.10 | 7.31 [4.45, 12.01] | 3.8e-15 | 138 |
| 15 years | 0.06 | 8.50 [5.69, 12.70] | 1.6e-25 | 135 |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: RX_L01XX – L01XX Other antineoplastic agents
GWS hits:
before L01XX Other antineoplastic agents
after L01XX Other antineoplastic agents
Loading survival analyses plot
Loading survival analyses table